Last reviewed · How we verify
Exosome Therapy
At a glance
| Generic name | Exosome Therapy |
|---|---|
| Sponsor | Iffat Anwar Medical Complex |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Exosomes Effect on Visual Function in CVI
- Contents of Circulating Extracellular Vesicles: Biomarkers in Colorectal Cancer Patients
- Safety and Feasibility of Nasal Delivery of Human Dental Follicle Mesenchymal Stem Cell-Derived Exosomes for Negative Symptoms in Treatment-Resistant Schizophrenia: A Pilot Study (EARLY_PHASE1)
- Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis (NA)
- Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction (PHASE2, PHASE3)
- Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer (NA)
- Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism (PHASE2)
- Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Exosome Therapy CI brief — competitive landscape report
- Exosome Therapy updates RSS · CI watch RSS
- Iffat Anwar Medical Complex portfolio CI